Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.
3 reports, 2 independent
Updated Aug 11
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Legend Biotech listed on Nasdaq and expanded into Ireland.1 source
Legend Biotech listed on NASDAQ and announced co-development of CAR-T therapy with Janssen.1 source
Janssen collaboration and CARVYKTI launch in Ireland are driving higher sales for Legend Biotech.1 source
Keep exploring
The entities involved
-
Legend Biotech
Biotech company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Ireland
sovereign state in Northwestern Europe
Related events
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- InnovAge listed its shares on the electronic stock exchange on September 8, 2026.
- Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.
- Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.